Disease Control and Prevention Vaccine Market Report

Europe Disease Control and Prevention Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 16, 2020
  • PAGES：139
  • REPORT CODE：GMM438104
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Disease Control and Prevention Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Disease Control and Prevention Vaccine Market Segmentations:

    By Player:

    • Pfizer

    • Sinovac Biotech Ltd

    • Astellas Pharma Inc

    • Serum Institute of India Pvt. Ltd

    • Merck & Co., Inc

    • Merck & Co, Inc

    • Sanofi

    • GSK

    • Daiichi Sankyo

    By Type:

    • Live-Attenuated

    • Inactivated

    • Recombinant Sub Unit and Toxoid

    By End-User:

    • Recombinant Sub Unit and Toxoid

    • Recombinant Sub Unit and Toxoid

    • Recombinant Sub Unit and Toxoid

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Disease Control and Prevention Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Live-Attenuated from 2014 to 2026

    • 1.3.2 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Inactivated from 2014 to 2026

    • 1.3.3 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • 1.4.2 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • 1.4.3 Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Disease Control and Prevention Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Disease Control and Prevention Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Live-Attenuated

      • 3.4.2 Market Size and Growth Rate of Inactivated

      • 3.4.3 Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    4 Segmentation of Disease Control and Prevention Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Disease Control and Prevention Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Disease Control and Prevention Vaccine for Recombinant Sub Unit and Toxoid

      • 4.4.2 Market Size and Growth Rate of Disease Control and Prevention Vaccine for Recombinant Sub Unit and Toxoid

      • 4.4.3 Market Size and Growth Rate of Disease Control and Prevention Vaccine for Recombinant Sub Unit and Toxoid

    5 Market Analysis by Major Regions

    • 5.1 Europe Disease Control and Prevention Vaccine Production Analysis by Top Regions

    • 5.2 Europe Disease Control and Prevention Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Disease Control and Prevention Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Disease Control and Prevention Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Disease Control and Prevention Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Disease Control and Prevention Vaccine Landscape Analysis

    • 7.1 Germany Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    8. UK Disease Control and Prevention Vaccine Landscape Analysis

    • 8.1 UK Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 8.2 UK Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    9. France Disease Control and Prevention Vaccine Landscape Analysis

    • 9.1 France Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 9.2 France Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    10. Italy Disease Control and Prevention Vaccine Landscape Analysis

    • 10.1 Italy Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    11. Spain Disease Control and Prevention Vaccine Landscape Analysis

    • 11.1 Spain Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    12. Poland Disease Control and Prevention Vaccine Landscape Analysis

    • 12.1 Poland Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    13. Russia Disease Control and Prevention Vaccine Landscape Analysis

    • 13.1 Russia Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Disease Control and Prevention Vaccine Landscape Analysis

    • 14.1 Switzerland Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    15. Turkey Disease Control and Prevention Vaccine Landscape Analysis

    • 15.1 Turkey Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Disease Control and Prevention Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Disease Control and Prevention Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Disease Control and Prevention Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Disease Control and Prevention Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Pfizer

      • 19.1.1 Pfizer Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Sinovac Biotech Ltd

      • 19.2.1 Sinovac Biotech Ltd Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Astellas Pharma Inc

      • 19.3.1 Astellas Pharma Inc Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Serum Institute of India Pvt. Ltd

      • 19.4.1 Serum Institute of India Pvt. Ltd Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck & Co., Inc

      • 19.5.1 Merck & Co., Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Merck & Co, Inc

      • 19.6.1 Merck & Co, Inc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sanofi

      • 19.7.1 Sanofi Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 GSK

      • 19.8.1 GSK Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Daiichi Sankyo

      • 19.9.1 Daiichi Sankyo Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 99 Figures and 129 Tables)

    • Figure Product Picture

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Live-Attenuated from 2014 to 2026

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Inactivated from 2014 to 2026

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • Figure Europe Disease Control and Prevention Vaccine Market Size and Growth Rate of Recombinant Sub Unit and Toxoid from 2014 to 2026

    • Figure Germany Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Disease Control and Prevention Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Disease Control and Prevention Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Disease Control and Prevention Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Disease Control and Prevention Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Disease Control and Prevention Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Live-Attenuated

    • Figure Market Size and Growth Rate of Inactivated

    • Figure Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Disease Control and Prevention Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Disease Control and Prevention Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    • Figure Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    • Figure Market Size and Growth Rate of Recombinant Sub Unit and Toxoid

    • Table Europe Disease Control and Prevention Vaccine Production by Major Regions

    • Table Europe Disease Control and Prevention Vaccine Production Share by Major Regions

    • Figure Europe Disease Control and Prevention Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Disease Control and Prevention Vaccine Consumption by Major Regions

    • Table Europe Disease Control and Prevention Vaccine Consumption Share by Major Regions

    • Table Germany Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table France Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Disease Control and Prevention Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table UK Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table France Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Disease Control and Prevention Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Disease Control and Prevention Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Disease Control and Prevention Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Disease Control and Prevention Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Sinovac Biotech Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac Biotech Ltd

    • Figure Sales and Growth Rate Analysis of Sinovac Biotech Ltd

    • Figure Revenue and Market Share Analysis of Sinovac Biotech Ltd

    • Table Product and Service Introduction of Sinovac Biotech Ltd

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Serum Institute of India Pvt. Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt. Ltd

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt. Ltd

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt. Ltd

    • Table Product and Service Introduction of Serum Institute of India Pvt. Ltd

    • Table Company Profile and Development Status of Merck & Co., Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co., Inc

    • Figure Revenue and Market Share Analysis of Merck & Co., Inc

    • Table Product and Service Introduction of Merck & Co., Inc

    • Table Company Profile and Development Status of Merck & Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc

    • Table Product and Service Introduction of Merck & Co, Inc

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US